Document text
Principal Investigator: Scott Dexter Boyd
Organization: STANFORD UNIVERSITY
Fiscal Year: 2023
Award: $541,840
Funding agency: National Institute of Allergy and Infectious Diseases
ABSTRACT – Project 3
The focus of Project 3 is to study antigen-specific B cell and plasma cell responses in the context of two timely
and fundamental topics in vaccinology: (i) Immunology of COVID-19 vaccines, and (ii) the impact of the
microbiota on immune responses to vaccination. The COVID-19 pandemic caused by the novel coronavirus
SARS-CoV-2 (CoV-2), and the vaccines developed to combat this pathogen, have underscored a need for
greater understanding of primary antibody responses in humans. We will use a systematic panel of cutting-
edge humoral immunity analyses to thoroughly characterize antibodies elicited by two CoV-2 vaccines,
and the B cell and plasma cell clonal populations required for B cell memory and sustained antibody
titers. Our focus will be on the serological, B cell and plasma cell responses elicited by a lipid nanoparticle mRNA
vaccine (Pfizer-BioNTech), and a Matrix M-adjuvanted recombinant protein vaccine (Novavax). Combining these
analyses with studies of innate immunity (Project 1) and T cell (Project 2) responses to these vaccines should
highlight cellular mechanisms correlated with the strength and durability of antibody responses. Rare serious
anaphylactoid adverse reactions have been reported for mRNA vaccines, particularly in individuals with a history
of food allergy, and those with IgG antibodies specific for polyethylene glycol (PEG). We will examine potential
B cell contributions to these anaphylactoid reactions, using specimens from affected individuals who
received SARS-COV-2 mRNA vaccines. Finally, we will address the role of the microbiome on humoral
immunity to vaccination, with a similar strategy of serological, memory B cell and plasma cell analyses
in participants with or without temporarily ablated microbiota following antibiotic treatment. Of particular
importance in the aforementioned studies, we will not only analyze peripheral blood B cells and plasmablasts,
but also monitor lymph node germinal center reactions by fine-needle aspiration, and sample bone
marrow plasma cells in the same participants, to comprehensively study humoral immunity to
vaccination in humans.
The combined impact of these investigations will likely be clinically significant in guiding the development of
future vaccination strategies by uncovering the B cell and plasma cell specificities, differentiation pathways, and
longevity stimulated by new SARS-CoV-2 vaccine platforms, and in clarifying the role of the microbiome in
vaccine responses to novel antigens.
Terms: <19S Gamma Globulin><2019 novel corona virus><2019 novel coronavirus><2019-nCoV><2019-nCoV vaccine><7S Gamma Globulin><Ablation><Acute><Adjuvant><Adverse reactions><Affect><Affinity><Allergic><Allergic to food><Allergy to food><Antibiotic Agents><Antibiotic Drugs><Antibiotic Therapy><Antibiotic Treatment><Antibiotics><Antibodies><Antibody Response><Antibody titer measurement><Antigenic Determinants><Antigens><Assay><Avidity><B blood cells><B cell><B cell receptor><B cells><B-Cell Antigen Receptor><B-Cells><B-Lymphocytes><B-cell><B-cell receptor repertoire sequencing><B-cell receptor sequencing><BCR repertoire sequencing><BCR seq><BCR sequencing><BCRseq><Basophilic Granulocyte><Basophils><Binding><Binding Determinants><Bioassay><Biologic Assays><Biological Assay><Blood><Blood Basophil><Blood Plasma Cell><Blood Reticuloendothelial System><Bone Marrow><Bone Marrow Reticuloendothelial System><COVID><COVID crisis><COVID epidemic><COVID pandemic><COVID-19><COVID-19 antigen><COVID-19 crisis><COVID-19 epidemic><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 pandemic><COVID-19 public health crisis><COVID-19 vaccine><COVID-19 virus><COVID19><COVID19 crisis><COVID19 epidemic><COVID19 global health crisis><COVID19 global pandemic><COVID19 health crisis><COVID19 pandemic><COVID19 public health crisis><COVID19 vaccine><COVID19 virus><CV-19><CV19><Cell Body><Cells><Clinical><Clinical Treatment Moab><Clone Cells><CoV disease><CoV emergence><CoV-2><CoV2><Collaborations><DNA><Data Analyses><Data Analysis><Deoxyribonucleic Acid><Development><Ensure><Epitopes><FNA><Fine Needle Aspirate><Fine needle aspiration biopsy><Fine-Needle Aspiration><Food Allergy><Food Hypersensitivity><Future><Germinal Center><Glycoproteins><History><Human><Humoral Immunities><IgG><IgM><Immune response><Immunity><Immunoglobulin G><Immunoglobulin M><Immunological response><Immunology><Individual><Infection><Innate Immunity><Investigation><Label><Length of Life><Longevity><Lymph Node Reticuloendothelial System><Lymph node proper><Lymphatic nodes><Macrogols><Measures><Memory B Cell><Memory B-Lymphocyte><Methods><Miscellaneous Antibiotic><Modern Man><Molecular Interaction><Monitor><Monoclonal Antibodies><Native Immunity><Natural Immunity><Non-Specific Immunity><Nonspecific Immunity><Participant><Pathogenicity><Pathway interactions><Phenotype><Plasma Cells><Plasmablast><Plasmacytes><Polyethylene Glycols><Polyethylene Oxide><Polyethyleneoxide><Polyoxyethylenes><Population><RNA immunization><RNA vaccination><RNA vaccine><RNA-based vaccine><Rabies><Rabies Human Diploid Cell Vaccine><Rabies Vaccines><Reaction><Recombinant Proteins><Recording of previous events><Reporting><Research Specimen><Role><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 antigen><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 pandemic><SARS-CoV-2 vaccine><SARS-CoV2><SARS-CoV2 antigen><SARS-CoV2 epidemic><SARS-CoV2 pandemic><SARS-CoV2 vaccine><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-coronavirus-2 vaccine><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Serology><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome CoV 2 vaccine><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome coronavirus 2 vaccine><Severe acute respiratory syndrome related corona virus 2><Shapes><Specificity><Specimen><Structure of germinal center of lymph node><T-Cells><T-Lymphocyte><Vaccination><Vaccinee><Vaccines><Variant><Variation><Viral><Viral Diseases><Virus><Virus Diseases><Wuhan coronavirus><adaptive immunity><antibody titering><antibody-based immunity><bacterial disease treatment><bacterial infectious disease treatment><biological systems><clinical significance><clinically significant><combat><corona virus disease><corona virus disease 2019><corona virus disease 2019 epidemic><corona virus disease 2019 pandemic><corona virus disease 2019 vaccine><corona virus emergence><coronavirus disease><coronavirus disease 2019><coronavirus disease 2019 antigen><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 vaccine><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus disease-19 vaccine><coronavirus disease-19 virus><coronavirus emergence><coronavirus infectious disease-19><data interpretation><data management><develop a vaccine><develop vaccines><development of a vaccine><developmental><emergent CoV><emergent corona virus><emergent coronavirus><emerging CoV><emerging corona virus><emerging coronavirus><global gene expression><global transcription profile><hCoV19><histories><host response><immune system response><immunization strategy><immunogen><immunoresponse><in vitro Assay><life span><lifespan><lipid based nanoparticle><lipid nanoparticle><lymph gland><lymph nodes><lymphnodes><lyssa><mAbs><mRNA immunization><mRNA vaccination><mRNA vaccine><mRNA-based vaccine><microbial consortia><microbial flora><microbiome><microbiota><microflora><monoclonal Abs><monoclonal antibody production><multiplex assay><multispecies consortia><nCoV><nCoV vaccine><nCoV-19 vaccine><nCoV19 vaccine><nCoV2><new CoV><new corona virus><new coronavirus><novel><novel CoV><novel corona virus><novel coronavirus><pathogen><pathway><peripheral blood><plasmocyte><recruit><response><severe acute respiratory syndrome coronavirus 2 antigen><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><social role><thymus derived lymphocyte><transcriptome><vaccinated individual><vaccinated participant><vaccinated patient><vaccinated person><vaccinated subject><vaccination strategy><vaccine against 2019-nCov><vaccine against SARS-CoV-2><vaccine against SARS-CoV2><vaccine against SARS-coronavirus-2><vaccine against Severe Acute Respiratory Syndrome CoV 2><vaccine against Severe acute respiratory syndrome coronavirus 2><vaccine development><vaccine for novel coronavirus><vaccine platform><vaccine response><vaccine responsiveness><vaccine-induced response><vaccinology><variants of concern><viral infection><virus infection><virus-induced disease>